Markets › United States › NYSE › BMY

Bristol-Myers Squibb Co

NYSE:BMYHealthcareCBOE:SPESGSTOXX:EDD24BP

$58.83−1.54%At closeAt close · Tue 20 Oct · ≈ AED 216.05 · Market cap $120.17B · Next earnings Thu 29 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	51.0%	57.7%	57.4%	56.3%	56.8%	71.1%	—	—
Operating margin	10.6%	20.6%	20.1%	18.8%	20.0%	28.5%	28.5%	+0.0 pts
Net margin	−21.2%	15.1%	13.7%	17.8%	−18.5%	14.6%	14.6%	+0.0 pts
EBITDA margin	11.6%	43.4%	41.6%	43.0%	6.6%	31.6%	—	—
Return on equity	−23.8%	19.5%	20.4%	27.3%	−54.8%	38.2%	38.1%	−0.1 pts
Return on assets	−7.6%	6.4%	6.5%	8.4%	−9.7%	7.8%	7.8%	+0.0 pts
Return on capital employed	4.5%	10.9%	12.4%	11.6%	14.0%	20.6%	—	—
Debt / equity	1.4×	1.3×	1.3×	1.4×	3.1×	2.6×	2.5×	−0.2%
Debt / assets	43.6%	41.7%	42.1%	43.6%	55.3%	52.4%	—	—
Interest coverage	3.2×	7.2×	7.5×	7.3×	5.0×	7.3×	—	—
Current ratio	1.6×	1.5×	1.2×	1.4×	1.3×	1.3×	1.3×	+0.0%
Quick ratio	1.5×	1.4×	1.1×	1.3×	1.1×	1.1×	—	—
Cash ratio	0.8×	0.6×	0.4×	0.5×	0.4×	0.4×	0.4×	+0.0%
Asset turnover	0.4×	0.4×	0.5×	0.5×	0.5×	0.5×	—	—
Inventory turnover	10.0×	9.4×	8.4×	7.4×	8.2×	5.2×	—	—
Receivables turnover	4.0×	3.7×	3.3×	2.9×	3.3×	3.3×	—	—
Dividend payout	−45.3%	62.9%	73.2%	59.1%	−54.3%	71.5%	—	—